{ "@context": "https://schema.org", "@graph": [ { "@type": "LegalCase", "@id": "case-7974", "postId": 7974, "name": "Picard Medical, Inc.", "description": "If you purchased or acquired securities in Picard Medical between September 2, 2025 and October 31, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Picard Medical, Inc. (\u201cPicard\u201d or the \u201cCompany\u201d) (NYSE: PMI) and reminds investors of the April 3, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) that Picard was the subject of a fraudulent stock promotion scheme involving social media-based misinformation and impersonated financial professionals; (2) that insiders and/or affiliates used offshore or nominee accounts to facilitate the coordinated dumping of shares during a price inflation campaign; and (3) that Picard\u2019s public statements and risk disclosures omitted any mention of the false rumors and artificial trading activity driving the stock price. Lead Plaintiff Deadline: April 3, 2026 \u00a0Call\u00a0Partner Josh Wilson\u00a0at\u00a0877-247-4292\u00a0or\u00a0212-983-9330 (Ext. 1310) Or\u00a0submit your information below\u00a0to learn about your rights.", "identifier": "PMI", "legal": { "court": "United States District Court for the Northern District of California", "jurisdiction": "Federal (United States), federal securities laws" }, "classPeriod": { "start": "09/02/2025", "end": "10/31/2025" }, "leadPlaintiffDeadline": "04/03/2026", "caseStatus": { "name": "", "slug": "" }, "practiceArea": { "name": "Securities Litigation", "slug": "securities-litigation" }, "url": "https://faruqilaw.com/case/picard-medical-inc/", "canonicalUrl": "https://faruqilaw.com/case/picard-medical-inc/", "datePublished": "2026-02-03T19:24:07+00:00", "dateModified": "2026-02-03T19:29:46+00:00", "associatedOrganization": { "@id": "case-7974-org" }, "legalService": { "@id": "case-7974-legalservice" }, "hasPart": [ { "@id": "case-7974-faq" }, { "@id": "case-7974-press-list" } ], "legalRepresentation": [ { "@id": "case-7974-attorney-516" }, { "@id": "case-7974-attorney-506" } ] }, { "@type": "Organization", "@id": "case-7974-org", "name": "Picard Medical, Inc.", "identifier": "PMI", "logo": "https://faruqilaw.com/wp-content/uploads/2025/05/logo.svg", "url": "https://picardmedical.com/" }, { "@type": "LegalService", "@id": "case-7974-legalservice", "name": "Faruqi & Faruqi, LLP", "url": "https://faruqilaw.com/", "telephone": "+1-212-983-9330", "logo": "https://faruqilaw.com/wp-content/uploads/2025/05/logo.svg", "address": { "@type": "PostalAddress", "streetAddress": "685 3rd Ave 26th Floor", "addressLocality": "New York", "postalCode": "10017", "addressRegion": "NY", "addressCountry": "US" }, "sameAs": [ "https://faruqilaw.com/", "https://maps.google.com/?cid=3247549158190754383" ] }, { "@type": "Person", "@id": "case-7974-attorney-516", "name": "James M. Wilson, Jr.", "worksFor": { "@id": "case-7974-legalservice" } }, { "@type": "Person", "@id": "case-7974-attorney-506", "name": "Robert W. Killorin", "worksFor": { "@id": "case-7974-legalservice" } }, { "@type": "FAQPage", "@id": "case-7974-faq", "mainEntity": [ { "@type": "Question", "name": "Why is Picard Medical under investigation by securities lawyers?", "acceptedAnswer": { "@type": "Answer", "text": "Picard Medical is being investigated over allegations it was tied to a fraudulent stock promotion campaign involving social media misinformation, impersonated financial professionals, and undisclosed activity that artificially inflated its share price." } }, { "@type": "Question", "name": "What is a stock promotion or pump-and-dump scheme like the one alleged at Picard Medical?", "acceptedAnswer": { "@type": "Answer", "text": "Such schemes typically involve spreading false or misleading information to inflate a stock\u2019s price, followed by insiders or affiliates selling shares at elevated prices, leaving public investors with losses when the price falls." } }, { "@type": "Question", "name": "What role did social media play in the Picard Medical allegations?", "acceptedAnswer": { "@type": "Answer", "text": "The complaint alleges false rumors and misleading statements about Picard Medical were spread through social media and fake financial personas, contributing to artificial trading activity and inflated stock prices." } }, { "@type": "Question", "name": "What are investors alleging about insider trading at Picard Medical?", "acceptedAnswer": { "@type": "Answer", "text": "Investors claim insiders or affiliates used offshore or nominee accounts to secretly sell shares during the price inflation period, benefiting from the promotion while public investors were unaware of the manipulation." } }, { "@type": "Question", "name": "What is the deadline to seek lead plaintiff status in the Picard Medical lawsuit?", "acceptedAnswer": { "@type": "Answer", "text": "Investors seeking to serve as lead plaintiff in the federal securities class action against Picard Medical must file a motion by April 3, 2026, to preserve their right to represent the shareholder class." } } ] }, { "@type": "NewsArticle", "@id": "case-7974-press-1", "headline": "Arizona biotech firm's shares nosedive after expansion of equity incentives", "url": "https://www.bizjournals.com/phoenix/news/2025/10/27/picard-medical-shares-plunge-equity-plan.html", "datePublished": "2025-10-27" }, { "@type": "NewsArticle", "@id": "case-7974-press-2", "headline": "Picard Medical\u2019s Stock Plummets Amid Concerns Over Muted Trading Session", "url": "https://www.timothysykes.com/news/picardmedicalinc-pmi-news-2025_10_25/", "datePublished": "2025-10-25" }, { "@type": "NewsArticle", "@id": "case-7974-press-3", "headline": "Picard Issues Statement on Intraday Stock Price", "url": "https://finance.yahoo.com/news/picard-issues-statement-intraday-stock-190700675.html", "datePublished": "2025-10-24" }, { "@type": "ItemList", "@id": "case-7974-press-list", "itemListElement": [ { "@type": "ListItem", "position": 1, "item": { "@id": "case-7974-press-1" } }, { "@type": "ListItem", "position": 2, "item": { "@id": "case-7974-press-2" } }, { "@type": "ListItem", "position": 3, "item": { "@id": "case-7974-press-3" } } ] } ] }

Picard Medical, Inc.

Picard Medical, Inc.

Join Action
Case Details
Ticker PMI
Class Period 09/02/2025 - 10/31/2025
Lead Plaintiff Deadline 04/03/2026
Days Left to Seek Plaintiff
58

If you are a Picard Medical investor who suffered a loss and would like to learn more, you can provide your information below:

If you purchased or acquired securities in Picard Medical between September 2, 2025 and October 31, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310).

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Picard Medical, Inc. (“Picard” or the “Company”) (NYSE: PMI) and reminds investors of the April 3, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) that Picard was the subject of a fraudulent stock promotion scheme involving social media-based misinformation and impersonated financial professionals; (2) that insiders and/or affiliates used offshore or nominee accounts to facilitate the coordinated dumping of shares during a price inflation campaign; and (3) that Picard’s public statements and risk disclosures omitted any mention of the false rumors and artificial trading activity driving the stock price.

📞 Lead Plaintiff Deadline: April 3, 2026

💻 Call Partner Josh Wilson at 877-247-4292 or 212-983-9330 (Ext. 1310)
Or submit your information below to learn about your rights.

Join Action
Picard Medical, Inc.
1
1
1
1

Accepted file types: xls, xlsx, doc, docx, pdf, jpg, jpeg, png, Max. file size: 50 MB, Max. files: 5.
You may redact account numbers from your uploaded documents.

File name:

File size:

Counsel
James M. Wilson, Jr.
jwilson@faruqilaw.com
Phone (212) 983-9330
Fax (212) 983-9331
Robert W. Killorin
rkillorin@faruqilaw.com
Phone (404) 847-0617
Fax (404) 506-9534
Office
New York
685 Third Avenue 26th Floor New York New York 10017
Phone (212) 983-9330
Fax (212) 983-9331

Our Offices

Our offices are nationwide. If you have any questions about a case or our firm, please contact us.
Send Us a Message
New York
685 Third Avenue 26th Floor
New York New York 10017
(877) 247-4292 / (212) 983-9330
(212) 983-9331
Los Angeles
1901 Avenue of the Stars Suite 1060
Los Angeles California 90067
(424) 256-2884
(424) 256-2885
Atlanta
3565 Piedmont Road NE Building Four, Suite 380
Atlanta Georgia 30305
(404) 847-0617
(404) 506-9534
Philadelphia
1617 JFK Boulevard, Suite 1550 Philadelphia
Pennsylvania 19103
(215) 277-5770
(215) 277-5771